BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Mikael Kozyra, Inger Johansson, Åsa Nordling, Shahid Ullah, Volker M. Lauschke, Magnus Ingelman-Sundberg. Human hepatic 3D spheroids as a model for steatosis and insulin resistanceScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32722-6
2
Elise A. Aeby, Patrick M. Misun, Andreas Hierlemann, Olivier Frey. Microfluidic Hydrogel Hanging-Drop Network for Long-Term Culturing of 3D Microtissues and Simultaneous High-Resolution ImagingAdvanced Biosystems 2018; 2(7): 1800054 doi: 10.1002/adbi.201800054
3
Franck Da-silva, Xavier Boulenc, Hélène Vermet, Pauline Compigne, Sabine Gerbal-Chaloin, Martine Daujat-Chavanieu, Sylvie Klieber, Patrick Poulin. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin BindingJournal of Pharmaceutical Sciences 2018; 107(7): 1957 doi: 10.1016/j.xphs.2018.03.001
4
Murat Cirit, Cynthia L. Stokes. Maximizing the impact of microphysiological systems with in vitro–in vivo translationLab on a Chip 2018; 18(13): 1831 doi: 10.1039/C8LC00039E
5
Carlemi Calitz, Josias H. Hamman, Stephen J. Fey, Krzysztof Wrzesinski, Chrisna Gouws. Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspectiveToxicology Mechanisms and Methods 2018; 28(5): 369 doi: 10.1080/15376516.2017.1422580
6
Abdul M. Oseini, Banumathi K. Cole, Danny Issa, Ryan E. Feaver, Arun J. Sanyal. Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitisHepatology International 2018; 12(1): 6 doi: 10.1007/s12072-017-9838-6
7
Charlotte J. Green, Thomas Marjot, Jeremy W. Tomlinson, Leanne Hodson. Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?Diabetes, Obesity and Metabolism 2019; 21(4): 749 doi: 10.1111/dom.13592
8
Chase P. Monckton, Salman R. Khetani. Drug-Induced Liver ToxicityMethods in Pharmacology and Toxicology 2018; : 213 doi: 10.1007/978-1-4939-7677-5_11
9
Banumathi K. Cole, Ryan E. Feaver, Brian R. Wamhoff, Ajit Dash. Non-alcoholic fatty liver disease (NAFLD) models in drug discoveryExpert Opinion on Drug Discovery 2018; 13(2): 193 doi: 10.1080/17460441.2018.1410135
10
David J Hughes, Tomasz Kostrzewski, Emma L Sceats. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systemsExperimental Biology and Medicine 2017; 242(16): 1593 doi: 10.1177/1535370217708976
11
Collin D. Edington, Wen Li Kelly Chen, Emily Geishecker, Timothy Kassis, Luis R. Soenksen, Brij M. Bhushan, Duncan Freake, Jared Kirschner, Christian Maass, Nikolaos Tsamandouras, Jorge Valdez, Christi D. Cook, Tom Parent, Stephen Snyder, Jiajie Yu, Emily Suter, Michael Shockley, Jason Velazquez, Jeremy J. Velazquez, Linda Stockdale, Julia P. Papps, Iris Lee, Nicholas Vann, Mario Gamboa, Matthew E. LaBarge, Zhe Zhong, Xin Wang, Laurie A. Boyer, Douglas A. Lauffenburger, Rebecca L. Carrier, Catherine Communal, Steven R. Tannenbaum, Cynthia L. Stokes, David J. Hughes, Gaurav Rohatgi, David L. Trumper, Murat Cirit, Linda G. Griffith. Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology StudiesScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-22749-0
12
Ozlem Yesil-Celiktas, Shabir Hassan, Amir K. Miri, Sushila Maharjan, Rawan Al-kharboosh, Alfredo Quiñones-Hinojosa, Yu Shrike Zhang. Mimicking Human Pathophysiology in Organ-on-Chip DevicesAdvanced Biosystems 2018; 2(10): 1800109 doi: 10.1002/adbi.201800109
13
Yasamin A. Jodat , Min G. Kang, Kiavash Kiaee, Gyeong J. Kim, Angel F.H. Martinez, Aliza Rosenkranz, Hojae Bae , Su R. Shin. Human-Derived Organ-on-a-Chip for Personalized Drug DevelopmentCurrent Pharmaceutical Design 2019; 24(45): 5471 doi: 10.2174/1381612825666190308150055
14
Fabrice A. Müller, Shana J. Sturla. Human in vitro models of nonalcoholic fatty liver diseaseCurrent Opinion in Toxicology 2019; 16: 9 doi: 10.1016/j.cotox.2019.03.001
15
Ajit Dash, William R. Proctor. Microfluidic Cell Culture Systems2019; : 159 doi: 10.1016/B978-0-12-813671-3.00006-2
16
M. Yu. Shkurnikov, E. N. Knyazev, K. A. Fomicheva, M. S. Kasatkin, V. V. Arkov, Yu. A. Makarova. Detection of Low-Abundant MicroRNAs with Hybridization MicrochipsBulletin of Experimental Biology and Medicine 2019; 166(6): 788 doi: 10.1007/s10517-019-04441-z
17
Alexandre J. S. Ribeiro, Xinning Yang, Vikram Patel, Rajnikanth Madabushi, David G. Strauss. Liver Microphysiological Systems for Predicting and Evaluating Drug EffectsClinical Pharmacology & Therapeutics 2019; 106(1): 139 doi: 10.1002/cpt.1458
18
Soufian Lasli, Han‐Jun Kim, KangJu Lee, Ceri‐Anne E. Suurmond, Marcus Goudie, Praveen Bandaru, Wujin Sun, Shiming Zhang, Niyuan Zhang, Samad Ahadian, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. A Human Liver‐on‐a‐Chip Platform for Modeling Nonalcoholic Fatty Liver DiseaseAdvanced Biosystems 2019; 3(8): 1900104 doi: 10.1002/adbi.201900104
19
Volker M. Lauschke, Reza Z. Shafagh, Delilah F. G. Hendriks, Magnus Ingelman‐Sundberg. 3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and ApplicationsBiotechnology Journal 2019; 14(7): 1800347 doi: 10.1002/biot.201800347
20
Ujjal Sarkar, Kodihalli C. Ravindra, Emma Large, Carissa L. Young, Dinelia Rivera-Burgos, Jiajie Yu, Murat Cirit, David J. Hughes, John S. Wishnok, Douglas A. Lauffenburger, Linda G. Griffith, Steven R. Tannenbaum. Integrated Assessment of Diclofenac Biotransformation, Pharmacokinetics, and Omics-Based Toxicity in a Three-Dimensional Human Liver-Immunocompetent Coculture SystemDrug Metabolism and Disposition 2017; 45(7): 855 doi: 10.1124/dmd.116.074005
21
Tarun Agarwal, Aruja Rustagi, Joyjyoti Das, Tapas Kumar Maiti. PAMAM dendrimer grafted cellulose paper scaffolds as a novel in vitro 3D liver model for drug screening applicationsColloids and Surfaces B: Biointerfaces 2018; 172: 346 doi: 10.1016/j.colsurfb.2018.08.062
22
Gregory H. Underhill, Salman R. Khetani. Advances in Engineered Human Liver Platforms for Drug Metabolism StudiesDrug Metabolism and Disposition 2018; 46(11): 1626 doi: 10.1124/dmd.118.083295
23
Kelsey Retting, Dwayne Carter, Candace Crogan-Grundy, Chirag Khatiwala, Leah Norona, Elizabeth Paffenroth, Umesh Hanumegowda, Alice Chen, Lisa Hazelwood, Lois Lehman-McKeeman, Sharon Presnell. Modeling Liver Biology and the Tissue Response to Injury in Bioprinted Human Liver TissuesApplied In Vitro Toxicology 2018; 4(3): 288 doi: 10.1089/aivt.2018.0015
24
Charlotte J. Green, Siôn A. Parry, Pippa J. Gunn, Carlo D.L. Ceresa, Fredrik Rosqvist, Marie-Eve Piché, Leanne Hodson. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human modelsHormone Molecular Biology and Clinical Investigation 2018; 0(0) doi: 10.1515/hmbci-2018-0038
25
A. M. Ortega-Prieto, J. K. Skelton, S. N. Wai, E. Large, M. Lussignol, G. Vizcay-Barrena, D. Hughes, R. A. Fleck, M. Thursz, M. T. Catanese, M. Dorner. 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infectionNature Communications 2018; 9(1) doi: 10.1038/s41467-018-02969-8
26
Kelly Tan, Philip Keegan, Miles Rogers, Mingjian Lu, James R. Gosset, Joe Charest, Shyam Sundhar Bale. A high-throughput microfluidic microphysiological system (PREDICT-96) to recapitulate hepatocyte function in dynamic, re-circulating flow conditionsLab on a Chip 2019; 19(9): 1556 doi: 10.1039/C8LC01262H
27
Jiu Deng, Zongzheng Chen, Xiuli Zhang, Yong Luo, Zhengzhi Wu, Yao Lu, Tingjiao Liu, Weijie Zhao, Bingcheng Lin. A liver-chip-based alcoholic liver disease model featuring multi-non-parenchymal cellsBiomedical Microdevices 2019; 21(3) doi: 10.1007/s10544-019-0414-9
28
Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues. Human-based systems: Mechanistic NASH modelling just around the corner?Pharmacological Research 2018; 134: 257 doi: 10.1016/j.phrs.2018.06.029
29
Seung Yeon Lee, Jong Hwan Sung. Gut–liver on a chip toward an in vitro model of hepatic steatosisBiotechnology and Bioengineering 2018; 115(11): 2817 doi: 10.1002/bit.26793
30
Jiu Deng, Xiuli Zhang, Zongzheng Chen, Yong Luo, Yao Lu, Tingjiao Liu, Zhengzhi Wu, Yu Jin, Weijie Zhao, Bingcheng Lin. A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interactionBiomicrofluidics 2019; 13(2): 024101 doi: 10.1063/1.5070088
31
Cliff Rowe, Mohsen Shaeri, Emma Large, Terri Cornforth, Angela Robinson, Tomasz Kostrzewski, Rowena Sison-Young, Christopher Goldring, Kevin Park, David Hughes. Perfused human hepatocyte microtissues identify reactive metabolite-forming and mitochondria-perturbing hepatotoxinsToxicology in Vitro 2018; 46: 29 doi: 10.1016/j.tiv.2017.09.012
32
Madeline Cooper, Joseph L. Charest, Jonathan Coppeta. Microfluidic Cell Culture Systems2019; : 1 doi: 10.1016/B978-0-12-813671-3.00001-3
33
Sophie Bauer, Charlotte Wennberg Huldt, Kajsa P. Kanebratt, Isabell Durieux, Daniela Gunne, Shalini Andersson, Lorna Ewart, William G. Haynes, Ilka Maschmeyer, Annika Winter, Carina Ämmälä, Uwe Marx, Tommy B. Andersson. Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes modelScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14815-w